Biohaven Pharmaceutical Holding Co Ltd.

WOLVERINE ASSET MANAGEMENT LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/3/2022

Shares

10,465

Value ($000)

1,524

Weight

0.0%

2020 Q2 - 2022 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/3/2022	1,524	0.0%	10,465	6/30/2022
2020 Q2	8/13/2020	1	0.0%	27	6/30/2020